Ensysce Biosciences, Inc. (ENSC)
Nasdaq: ENSC · CIK 0001716947 · United States
Every official Ensysce Biosciences, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ENSC filings
Ensysce Biosciences, Inc. documents
- Ensysce Biosciences, Inc. 10-K 2026ENSC 10-K 2026: annual report for fiscal 2026
- Ensysce Biosciences, Inc. 10-K 2025ENSC 10-K 2025: annual report for fiscal 2025
- Ensysce Biosciences, Inc. 10-K 2024ENSC 10-K 2024: annual report for fiscal 2024
- Ensysce Biosciences, Inc. 10-K 2023ENSC 10-K 2023: annual report for fiscal 2023
- Ensysce Biosciences, Inc. 10-K 2022ENSC 10-K 2022: annual report for fiscal 2022
- Ensysce Biosciences, Inc. 10-Q 2026ENSC 10-Q 2026: quarterly report for fiscal 2026
- Ensysce Biosciences, Inc. 10-Q 2025ENSC 10-Q 2025: quarterly report for fiscal 2025
- Ensysce Biosciences, Inc. 10-Q 2024ENSC 10-Q 2024: quarterly report for fiscal 2024
- Ensysce Biosciences, Inc. 10-Q 2023ENSC 10-Q 2023: quarterly report for fiscal 2023
- Ensysce Biosciences, Inc. 10-Q 2022ENSC 10-Q 2022: quarterly report for fiscal 2022
- Ensysce Biosciences, Inc. 8-K 2026ENSC 8-K 2026: current report for fiscal 2026
- Ensysce Biosciences, Inc. 8-K 2025ENSC 8-K 2025: current report for fiscal 2025
- Ensysce Biosciences, Inc. 8-K 2024ENSC 8-K 2024: current report for fiscal 2024
- Ensysce Biosciences, Inc. 8-K 2023ENSC 8-K 2023: current report for fiscal 2023
- Ensysce Biosciences, Inc. 8-K 2022ENSC 8-K 2022: current report for fiscal 2022
- Ensysce Biosciences, Inc. DEF 14A 2026ENSC DEF 14A 2026: proxy statement for fiscal 2026
- Ensysce Biosciences, Inc. DEF 14A 2025ENSC DEF 14A 2025: proxy statement for fiscal 2025
- Ensysce Biosciences, Inc. DEF 14A 2024ENSC DEF 14A 2024: proxy statement for fiscal 2024
- Ensysce Biosciences, Inc. DEF 14A 2023ENSC DEF 14A 2023: proxy statement for fiscal 2023
- Ensysce Biosciences, Inc. DEF 14A 2022ENSC DEF 14A 2022: proxy statement for fiscal 2022
- Ensysce Biosciences, Inc. Form 4 2026ENSC Form 4 2026: insider trading filing for fiscal 2026
- Ensysce Biosciences, Inc. Form 4 2025ENSC Form 4 2025: insider trading filing for fiscal 2025
- Ensysce Biosciences, Inc. Form 4 2024ENSC Form 4 2024: insider trading filing for fiscal 2024
- Ensysce Biosciences, Inc. Form 4 2023ENSC Form 4 2023: insider trading filing for fiscal 2023
- Ensysce Biosciences, Inc. Form 4 2022ENSC Form 4 2022: insider trading filing for fiscal 2022
- Ensysce Biosciences, Inc. S-1 2026ENSC S-1 2026: registration statement for fiscal 2026
- Ensysce Biosciences, Inc. S-1 2025ENSC S-1 2025: registration statement for fiscal 2025
- Ensysce Biosciences, Inc. S-1 2024ENSC S-1 2024: registration statement for fiscal 2024
- Ensysce Biosciences, Inc. S-1 2023ENSC S-1 2023: registration statement for fiscal 2023
- Ensysce Biosciences, Inc. S-1 2022ENSC S-1 2022: registration statement for fiscal 2022
- Ensysce Biosciences, Inc. 13F 2026ENSC 13F 2026: institutional holdings for fiscal 2026
- Ensysce Biosciences, Inc. 13F 2025ENSC 13F 2025: institutional holdings for fiscal 2025
- Ensysce Biosciences, Inc. 13F 2024ENSC 13F 2024: institutional holdings for fiscal 2024
- Ensysce Biosciences, Inc. 13F 2023ENSC 13F 2023: institutional holdings for fiscal 2023
- Ensysce Biosciences, Inc. 13F 2022ENSC 13F 2022: institutional holdings for fiscal 2022
More companies